DawMed Systems PLC
25 June 2007
For immediate release 25 June 2007
DAWMED SYSTEMS PLC
('Dawmed' or the 'Company')
SETTLEMENT OF LEGAL PROCEEDINGS
The Board of Dawmed Systems plc ('Dawmed' or 'the Company'), the AIM listed
medical device company which designs, manufactures, sells and services
healthcare decontamination equipment used by NHS Trust hospitals, private
hospitals, clinics and Primary Care practitioners, is pleased to announce that a
full, final and satisfactory settlement has been reached with the trade debtor
against whom Dawmed International Limited, the Company's operating subsidiary
company, instigated legal proceedings in December 2006, and also that a
satisfactory ongoing relationship has been established with the said trade
debtor.
Enquiries:
Kevin M Gilmore Tel: 01789 740010
Executive Chairman Mob: 07785 396666
Beaumont Cornish Limited
Roland Cornish Tel: 0207 628 3396
Bishopsgate Communications Limited
Maxine Barnes
Dominic Barretto Tel: 0207 562 3350
For further information about Dawmed International Limited please visit the web
site at www.dawmed.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.